A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study is a multi-center, randomized, prospective open-label study to assess the efficacy
and safety of combination of peginterferon alfa-2b (40kD, Y-shape) and GM-CSF in
interferon-naïve chronic hepatitis B patients with HBeAg positive. Patients were randomized
to one of the 2 groups to receive different antiviral treatment.